How can the cancellation of drug licences after the cough syrup deaths improve drug regulation and public health in India?
After a tragic incident involving cough syrup, the government cancelled a pharma company’s licences. I want to understand how such actions can strengthen the regulatory system and what further steps are needed to ensure drug safety.